Correlation Between CanSino Biologics and SCANSOURCE (SC3SG)

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CanSino Biologics and SCANSOURCE (SC3SG) at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CanSino Biologics and SCANSOURCE (SC3SG) into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CanSino Biologics and SCANSOURCE, you can compare the effects of market volatilities on CanSino Biologics and SCANSOURCE (SC3SG) and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CanSino Biologics with a short position of SCANSOURCE (SC3SG). Check out your portfolio center. Please also check ongoing floating volatility patterns of CanSino Biologics and SCANSOURCE (SC3SG).

Diversification Opportunities for CanSino Biologics and SCANSOURCE (SC3SG)

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between CanSino and SCANSOURCE is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding CanSino Biologics and SCANSOURCE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCANSOURCE (SC3SG) and CanSino Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CanSino Biologics are associated (or correlated) with SCANSOURCE (SC3SG). Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCANSOURCE (SC3SG) has no effect on the direction of CanSino Biologics i.e., CanSino Biologics and SCANSOURCE (SC3SG) go up and down completely randomly.

Pair Corralation between CanSino Biologics and SCANSOURCE (SC3SG)

Assuming the 90 days trading horizon CanSino Biologics is expected to generate 0.84 times more return on investment than SCANSOURCE (SC3SG). However, CanSino Biologics is 1.19 times less risky than SCANSOURCE (SC3SG). It trades about -0.15 of its potential returns per unit of risk. SCANSOURCE is currently generating about -0.14 per unit of risk. If you would invest  380.00  in CanSino Biologics on November 3, 2024 and sell it today you would lose (38.00) from holding CanSino Biologics or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

CanSino Biologics  vs.  SCANSOURCE

 Performance 
       Timeline  
CanSino Biologics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, CanSino Biologics may actually be approaching a critical reversion point that can send shares even higher in March 2025.
SCANSOURCE (SC3SG) 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SCANSOURCE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, SCANSOURCE (SC3SG) is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

CanSino Biologics and SCANSOURCE (SC3SG) Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CanSino Biologics and SCANSOURCE (SC3SG)

The main advantage of trading using opposite CanSino Biologics and SCANSOURCE (SC3SG) positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CanSino Biologics position performs unexpectedly, SCANSOURCE (SC3SG) can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCANSOURCE (SC3SG) will offset losses from the drop in SCANSOURCE (SC3SG)'s long position.
The idea behind CanSino Biologics and SCANSOURCE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Content Syndication
Quickly integrate customizable finance content to your own investment portal